Novo Holdings
89 portfolio companies · 18 on the map · $4.9B raised · 17 cities
Portfolio map
18 Novo Holdings portfolio companies on the map.
Portfolio companies

Harmony Biosciences
Plymouth Meeting
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Pharmaceutical Manufacturing$1.7BEst. 2017
Praxis Precision Medicines
Boston
The era of genetic neuroscience has arrived
Biotechnology Research$1.7BEst. 2015
Akebia Therapeutics
Cambridge
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Biotechnology Research$442.5MEst. 2007
Alentis Therapeutics
Allschwil
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Pharmaceutical Manufacturing$365.4MEst. 2019
Milestone Pharmaceuticals
Montreal
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Biotechnology Research$360.9MEst. 2007
FIRE1
Dublin
Our purpose is to help millions of people living with heart failure to get their normal back.
Medtech & devices$115.4MEst. 2014
Cleveland Diagnostics
Cleveland
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
Biotechnology Research$111MEst. 2013
Matr Foods
Copenhagen
MATR Foods is a food-tech startup that provides fungi-based food ingredients.
Agritech & foodtech$38.5MEst. 2021
Phasecraft
Bristol
Phasecraft develops quantum algorithms and related intellectual property for scientific and industrial applications.
Technology, Information and Internet$22.5MEst. 2019
AnaCardio
Stockholm
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Biotech$17.3M
Quanta
San Francisco
Quanta is the accounting service for software businesses who want to get their finances right, without delay. We’re the only service that can provide critical business metrics up to date daily, and will close your books as fast as the data
Software Development$15MEst. 2023
GlycoEra
Zurich
Advancing Glycan Mediated Therapy
Biotech$12.4MEst. 2020
Chromologics
Copenhagen
Natural Colors Crafted By Fermentation
Biotech$6.7MEst. 2017
Octave
Mechelen
Mechelen-based · energy.
Energy$750KEst. 2020
Clever Care Health Plan
Huntington Beach
Clever Care provides culturally sensitive, language-accessible healthcare that removes language barriers to timely and effective treatment and aligns its services with members’ needs.
InsuranceSeries CEst. 2019
Mission Bio
South San Francisco
Mission Bio solves complex biological problems using precision engineering, innovative biochemistry, and supported bioinformatics. Spun out from UCSF in 2014, it leverages Adam Abate’s droplet microfluidics to unlock single-cell biology for
BiotechnologyEst. 2014- AT
Alveus Therapeutics
Philadelphia
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Biotechnology ResearchSeries AEst. 2023 
MapLight Therapeutics
Redwood City
Maplight is a biopharmaceutical company that discovers and develops novel therapeutics for central nervous system disorders, with a focus on bringing new treatments to patients.
BiotechnologySeries DEst. 2018
More portfolio companies
71 more Novo Holdings investments we track beyond the map.
TempusChicago · Debt Financing
ArcellxRedwood City · Series C
Terremoto BiosciencesSan Francisco · Series C
Qure AIAndheri · Series D
Oxford Nanopore TechnologiesOxford · Post-IPO Equity
AvailityJacksonville · Secondary Market
NoomNew York · Series F
CARGO TherapeuticsSan Mateo · Post-IPO Equity
Kivu BioscienceSan Francisco · Series A
Rondo TherapeuticsHayward · Series A
KebotixCambridge · Series A
ElektrofiBoston · Series C
Asgard TherapeuticsLund · Series A
SUBRA A/SFarum · Series A
VestaronDurham · Series C
Reunion NeuroscienceToronto · Series A
MinervaxHellerup · Venture
Verve TherapeuticsBoston · Series B
BIOMILQDurham · Series A
Verana HealthSan Francisco · Series E
EnergyReNew York · Private Equity
Nalu MedicalCarlsbad · Series E
BiomasonDurham · Series C
HalodocJakarta · Series D
CIRCTECLondon · Venture
Doctor AnywhereSingapore · Series C
Hummingbird BioscienceWoodlands · Series C
GenomaticaSan Diego · Series C
Spruce BiosciencesSouth San Francisco · Post-IPO Equity
Aligos TherapeuticsSan Francisco · Series B
KalVista PharmaceuticalsCambridge · Series B
Callio TherapeuticsSeattle · Series A
Myricx BioLondon · Series A
Magenta MedicalKadima · Venture
21st.BIOVirum · Venture
Centauri TherapeuticsAlderley Park · Series A
AgNextMohali · Venture
Acesion PharmaFrederiksberg · Series B
WCGPrinceton · Private Equity
Elo Life SystemsDurham · Series A
Manipal HospitalsBangalore · Secondary Market
ExscientiaOxford · Series D
iRhythm TechnologiesSan Francisco · Series E
PTC TherapeuticsSouth Plainfield · Private Equity
AdaptimmuneOxford · Series A
Deep Branch BiotechnologyNottingham · Series A
RevagenixSan Mateo · Series B
Tarveda TherapeuticsWatertown · Series D
Hoba TherapeuticsCopenhagen · Series A
NBE-TherapeuticsBasel · Series B
Outpost MedicineIndianapolis · Series A
Morphic TherapeuticWaltham · Series B
Reata PharmaceuticalsIrving · Venture
AffimedHeidelberg · Series E
Oxford BioMedicaOxford · Post-IPO Equity
OrexoUppsala · Post-IPO Equity
IVERIC bioPrinceton · Post-IPO Equity
Entasis TherapeuticsWaltham · Series B
HTG Molecular DiagnosticsTucson · Series D
InogenGoleta · Venture
Checkmate PharmaceuticalsCambridge · Series C
ClarioPhiladelphia · Private Equity
EnvirotainerSollentuna · Private Equity
SonionRoskilde · Venture
LePure BiotechShanghai · Series C
NuevolutionCopenhagen · Series B
Lux BiosciencesJersey City · Series B
EpitherapeuticsFoster City · Funding
Protein ForestLexington · Series A
ZS PharmaCoppell · Series D
Chr. HansenHørsholm · Post-IPO Secondary
Portfolio map
18 Novo Holdings portfolio companies on the map.